These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4923653)

  • 1. L-dopa in Parkinsonism and the influence of previous thalamotomy.
    Hughes RC; Polgar JG; Weightman D; Walton JN
    Br Med J; 1971 Jan; 1(5739):7-13. PubMed ID: 4923653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic uses and side effects of L-dopa.
    Boshes B
    Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C
    Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levodopa and Parkinsonism. A double-blind study].
    Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
    Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
    Kaufmann W; Butz P; Wiesendanger M
    Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 9. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of an experimental anticholinergic drug, elantrine, in treating the tremor of parkinsonism.
    Rix A
    Adv Exp Med Biol; 1977; 90():277-81. PubMed ID: 337773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
    Giuffrè R; Gambacorta D
    Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of parkinsonism with levodopa.
    Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K; Mutsuga N; Takaoka Y; Takeda A
    No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract]   [Full Text] [Related]  

  • 15. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
    Mars H; Libman I; Schwartz AM; Gillo-Joffroy L; Barbeau A
    Can Psychiatr Assoc J; 1972 Apr; 17(2):123-31. PubMed ID: 5036506
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects of L-dopa treatment.
    Greenburg J
    Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of severe parkinsonism with L-dopa.
    Reef HE; Joffe R; Milletz H
    S Afr Med J; 1971 May; 45(18):504-7. PubMed ID: 4941208
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
    Völler GW; Muschard F
    Acta Neurol Scand; 1974; 50(3):391-3. PubMed ID: 4525037
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.